Menu
Close
Our Pipeline.
Our innovation converges with a commitment to advancing healthcare. Our robust project pipeline is at the forefront of cutting-edge biotechnological advancements, aimed at addressing unmet medical needs and improving patient outcomes.
Davunetide
Autism – ADNP Syndrome
Pre-Clinical
Phase 1
Phase 2
Phase 3
Approval
Progressive Supranuclear Palsy (PSP)
Pre-Clinical
Phase 1
Phase 2
Phase 3
Approval
Mild Cognitive Impairment (MCI)
Pre-Clinical
Phase 1
Phase 2
Phase 3
Approval
Schizophrenia
Pre-Clinical
Phase 1
Phase 2
Phase 3
Approval
Alzheimer’s
Pre-Clinical
Phase 1
Phase 2
Phase 3
Approval
ProtEx
Platform
Pre-Clinical
Phase 1
Phase 2
Phase 3
ARDS
Pre-Clinical
Phase 1
Phase 2
Phase 3
COPD
Pre-Clinical
Phase 1
Phase 2
Phase 3